期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 54, 期 8, 页码 2701-2713出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm1015022
关键词
-
资金
- J-Pharma Co., Ltd. (Tokyo, Japan)
- National Center for Research Resources at the National Institutes of Health (NCRR/NIH) [5UL1RR025780]
- Grants-in-Aid for Scientific Research [21390073] Funding Source: KAKEN
The kidneys are a vital organ in the human body. They serve several purposes including homeostatic functions such as regulating extracellular fluid volume and maintaining acid-base and electrolyte balance and are essential regarding the excretion of metabolic waste. Furthermore, the kidneys play an important role in uric acid secretion/reabsorption. Abnormalities associated with kidney transporters have been associated with various diseases, such as gout. The current study utilized Xenopus oocytes expressing human uric acid transporter 1 (hURAT1; SLC22A12) as an in vitro method to investigate novel compounds and their ability to inhibit (14)C-uric acid uptake via hURAT1. We have prepared and tested a series of 2-ethyl-benzofuran compounds and probed the hURAT1 in vitro inhibitor structure activity relationship. As compared to dimethoxy analogues, monophenols formed on the C ring showed the best in vitro inhibitory potential. Compounds with submicromolar (i.e., IC(50) < 1000 nM) inhibitors were prepared by brominating the corresponding phenols to produce compounds with potent uricosuric activity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据